Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5550864

NCCNc1cc2c(=O)c(C(N)=O)cn(C3CC3)c2cc1Cl.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPT P10636 1/20 0.39
CYP1A2 P05177 1/20 0.39
TOP2A P11388 1/20 0.39
CYP2C9 P11712 1/20 0.39
TOP2B Q02880 1/20 0.39
TOP1 P11387 1/20 0.38
PIK3CG P48736 2/20 0.37
PIK3CD O00329 1/20 0.37
PIK3R1 P27986 1/20 0.37
PIK3CA P42336 1/20 0.37
GSK3B P49841 2/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5546378 0.89 TOP1 (0.47) MEN1KMT2AALDH1A1KDM4ELMNA
Trifluoroacetic Acid SCHEMBL27545954 0.88 KDM4E (0.41) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL3977252 0.87 KDM4E (0.48) ALDH1A1KDM4ELMNAHPGDHSD17B10
Hydrochloric Acid SCHEMBL5272541 0.86 KDM4E (0.47) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL4914088 0.83 ALDH1A1 (0.39) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL5549155 0.82 KDM4E (0.46) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL5544767 0.79 MEN1 (0.38) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL3819773 0.79 KDM4E (0.44) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL4550715 0.78 KDM4E (0.46) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL27659709 0.78 KDM4E (0.36) MEN1KMT2AALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202221-B2 Macrolides GLAXO GROUP LIMITED (GB) 2007-04-10 US disclosed
US-20050080025-A1 Macrolides PLIVA D.D. (HR) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080025-A1 Macrolides IL17A, CYP51A1, IL15 MEN1 2726/4885KMT2A 4423/4885ALDH1A1 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.